Veeda’s successful execution of a bioequivalence study involving ovarian cancer patients
May 20, 2021
May 20, 2021
May 17, 2021
May 5, 2021
February 23, 2021
February 23, 2021
Prior to joining Veeda Clinical Research in May 2019, Mr Tandon was Partner-Operations with CX Advisors LLC, an India mid-market focused private equity investment advisor, where he worked with portfolio companies in developing and enabling strategic initiatives and performance improvements and supporting operational due diligence of target investments. Prior to CX, Mr. Tandon was a Managing Director with The Rohatyn Group and a Director with CVCI, prior to its acquisition by The Rohatyn Group. During the eight years he worked there Mr. Tandon identified, managed and exited a large number of companies across a wide spectrum of industries including, among others, automotive, financial services, IT, IT enabled services, infrastructure, oil & gas services and mining. Prior to CVCI, Mr. Tandon gained 15 years of banking experience with Citibank during which he managed and advised several mid and large corporate clients across diverse industries. Mr. Tandon earned an MBA from the Indian Institute of Management, Ahmedabad and a B.Engineering (Honours) degree in Electrical Engineering from Delhi College of Engineering, Delhi University.
Prior to joining the Investment Advisor in 2009, Ms. Ahuja served in the Funds Administration team at Actis where she was responsible for investor relations and reporting, accounting and compliance. Ms. Ahuja began her career in the Assurance division of Ernst & Young. Ms. Ahuja is a qualified Chartered Accountant (2006) and has a B.Com. (Honours) degree from Delhi University (2003).
Mr. Apurva Shah is a founder and Director of Veeda Clinical Research. He has a MBA in International Finance & Entrepreneurship from Babson College in Boston USA. With his strong entrepreneurial and organizational skills, he has been able to grow Veeda to become one of the premier CROs in the country. As a Board member, he gives strategic and financial direction to all Group Companies. Mr. Shah strongly believes in giving back to the society and hence as a Managing Committee member of the NGO ‘Each One Teach One’ (www.eotoindia.org) he helps in furthering the cause of education and development of under privileged children in cities and tribal areas. During his tenure as the Chairman of Association of CROs in India (www.acroindia.org) from 2010-2014, he was able to grow the association membership 5 fold, increase the awareness of the industry and work with the Regulatory Agencies to facilitate the growth of the industry. He believes that if done in an ethical manner, clinical research is a very attractive socio-economic opportunity for India. He is on the Governing Board of the Life Science Sector Skill Development Council (www.lsssdc.in) set up by the Government of India. He has also been a member of the Pharma committee of CII for the past 5 years. Mr. Apurva Shah and Mr. Binoy Gardi were awarded the prestigious Entrepreneur of the year in 2009 by the BioSpectrum magazine as recognition for his contribution to the industry and were awarded the SME Entrepreneur of the year by Business Today and Yes Bank in 2010.
Mr. Binoy Gardi is a founder and Director of Veeda Clinical Research. Mr. Gardi is responsible for strategic planning, developing and implementing new services and establishing relationships with the firm’s growing client base. His entrepreneurial vision has led the Company to become one of the fastest growing CROs in India. Mr. Gardi also spends part of his time pursuing his philanthropic ventures. He is responsible for setting up and running two 500 bed hospitals in India. Both hospitals offer free healthcare and medicines. He is one of the main Trustees of RD Gardi Medical College which has now 150 seats and a total of 850 students for MBBS and post graduate courses. Mr Gardi is also Managing Trustee of Shri Bharat Saraswati Mandir Sansad Trust, this is one of the oldest trusts in Gujarat and has 16 educational units with over 3000 students. Mr. Gardi has won the Entrepreneur of the year in 2009 by BioSpectrum magazine and was awarded the SME entrepreneur of the year by BUSINESS TODAY and YES BANK in 2010. Mr. Gardi has a BSc in Business Management from Kings College London and is also a qualified lawyer from the UK. He has also received a diploma from London Business School in Investment Management.
Dr. Marthak comes with a rich experience in Clinical Research of nearly 40 years. Dr. Marthak has conducted many Phase 1 studies including First in Human studies, and complex clinical trials. He has held senior positions in several Indian and Global pharmaceutical companies such as Ciba – Geigy (Novartis), GSK, Pfizer and Ranbaxy, and in leading CROs and has experience in conducting clinical trials across several geographies including USA, UK, Europe, China, Japan and South Africa. Dr. Marthak’s last assignment was as a Member of the Board of Directors in Lambda Therapeutic Research Ltd. Dr. Marthak was a Board member during our formative years.
Dr. Marthak is highly respected amongst regulatory authorities for his knowledge of international clinical research guidelines. He is one of the accredited members for GCP training by CDSA, India and contributed to the New Clinical Trial Rules implemented in March 2019. Dr. Marthak is also the Co-Chairman of the Medical Committee of IDMA and a member of the Pharmaceutical and Biotech Committees of the Confederation of Indian Industries. He is a renowned speaker in International and National Conferences, besides being actively involved in academics. Dr. Marthak is a qualified M.D. in Internal Medicine from Grant Medical College, Fellow of American College of Clinical Pharmacology, Fellow of Royal Society of Medicine, U.K. and Fellow of Faculty of Pharmacology, University of London.
Prior to joining the Investment Advisor in 2013, Mr. Sahni worked in Mumbai with Exponentia Capital, an emerging India-focused private equity firm. Prior to that, Mr. Sahni served in CVCI’s investment team and focused on investments in the financial services, energy and manufacturing sectors. Prior to CVCI, Mr. Sahni served in the Corporate and Investment Bank division of Citibank in Mumbai. Mr. Sahni began his career in the assurance advisory business of Arthur Andersen. At the Investment Advisor, Mr. Sahni is focused on the financial services, healthcare and consumer products sectors. He is the investment officer on the following Fund 1 portfolio companies — Thyrocare, Nueclear and Mrs Bectors Speciality Foods. Mr. Sahni has served as a special invitee on the board of the following Fund 1 portfolio companies —Mrs. Bectors Speciality Foods, Thyrocare and Nueclear. Mr. Sahni earned an MBA degree from the Indian School of Business, Hyderabad (2004), where he was a scholarship student. Mr. Sahni is a qualified Chartered Accountant (2001) and has a B.A. Honors degree in Economics from St. Stephen’s College, Delhi University (1998).
Prior to joining the Investment Advisor in 2010, Mr. Chhachhi was a Director with CVCI, where he gained 15 years of investing experience. During his tenure with CVCI, Mr. Chhachhi worked to identify, manage and exit a large number of companies across a wide spectrum of industries including, among others, IT, pharmaceutical and specialty chemicals, IT enabled services, financial services, automotive, metals and mining, infrastructure, oil & gas services, media and textiles. Prior to CVCI, Mr. Chhachhi spent two years as an equity research analyst at a Citi-affiliated brokerage firm, Citicorp Securities & Investments Limited. Mr. Chhachhi has served on the boards of Fund 1 portfolio companies Thyrocare, Nueclear, Thyrocare Gulf, Sutures and Natco. Prior to this, Mr. Chhachhi also served as a board member or as an observer on the board of several CVCI portfolio companies, such as i-FLEX, Jubilant Organosys, Sasken Technologies, RelQ Software, Newgen Software, Himadri Industries, Techno Electric, IVRCL, Perlecan Pharma, International Tractors, Jai Balaji, and Globe Capital, among others. Mr. Chhachhi holds an MBA from the Jamnalal Bajaj Institute of Management Studies, University of Mumbai and a B.Sc. degree in Computer Science from St. Stephen’s College, Delhi University.